Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema

By Goel Neha  

International Ophthalmology, Vol. 31, Iss. 1, 2011-02 ,pp. : 39-42

Springer Publishing Company

Access to resources Recommend Favorite

Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial

By Ahmadieh Hamid  

Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 246, Iss. 4, 2008-04 ,pp. : 483-489

Springer Publishing Company

Access to resources Recommend Favorite

Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: one-year results

By Beutel Julia   Ziemssen Focke   Lüke Matthias   Partsch Michael   Bartz-Schmidt Karl-Ulrich   Gelisken Faik  

International Ophthalmology, Vol. 30, Iss. 1, 2010-02 ,pp. : 15-22

Springer Publishing Company

Access to resources Recommend Favorite

Single injection of triamcinolone versus three repeated injections of bevacizumab for treatment of diabetic macular edema

By Taş Mehmet  

International Ophthalmology, Vol. 33, Iss. 4, 2013-08 ,pp. : 375-380

Springer Publishing Company

Access to resources Recommend Favorite

Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema

By Ozkiris Abdullah   Evereklioglu Cem   Oner Ayse   Erkiliç Kuddusi  

Documenta Ophthalmologica, Vol. 109, Iss. 2, 2004-09 ,pp. : 139-145

Springer Publishing Company

Access to resources Recommend Favorite